Ono Pharmaceutical

An imaginary winners podium is modelled and rendered

Biotech

Merck KGaA tumor trial hits goal, teeing up Daiichi, Ono rivalry

The TGCT hit its primary endpoint, teeing up an option decision that could establish Merck’s as a global rival to Daiichi and Ono in the indication.

Nick Paul Taylor Nov 12, 2024 4:46am

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Ono inks $700M biobuck deal to bag preclinical LigaChem ADC

Oct 10, 2024 9:40am

pivot change turnaround direction walk away

Shattuck axes CD47 program, cuts 40% of staff over weak data

Oct 1, 2024 8:22am

A series of dice with a bag on them illustrating cost cuts

Cue lays off 25%, prioritizing preclinical autoimmune assets

Jul 26, 2024 4:29am

Graphic image of a cardboard box delivered to a doorstep with a welcome mat

Equillium delivers new lupus data to Ono's doorstep

Apr 1, 2024 10:53am

pay deal hand over cash licensing transaction money

Ono taps Shattuck for $227M bifunctional fusion protein deal

Feb 13, 2024 8:29am